Biotron Ltd (BIT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.322x

Based on the latest financial reports, Biotron Ltd (BIT) has a cash flow conversion efficiency ratio of -0.322x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-868.42K ≈ $-614.46K USD) by net assets (AU$2.70 Million ≈ $1.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biotron Ltd balance sheet quality to measure how much of total assets are equity-financed.

Biotron Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Biotron Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Biotron Ltd (BIT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Biotron Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotron Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Norwest Minerals Ltd
AU:NWM
-0.015x
BlackRock Frontiers Investment Trust plc
LSE:BRFI
-0.044x
Eugene Special Purpose Acquisitions 4 Company
KQ:321260
0.013x
Red Sky Energy Ltd
AU:ROG
0.032x
Knosys Ltd
AU:KNO
-0.200x
Albion Resources Ltd
AU:ALB
-0.617x
TMM REAL EST.DEV.GDR S 1
F:TR61
N/A
Xpon Technologies Group Ltd
AU:XPN
-1.594x

Annual Cash Flow Conversion Efficiency for Biotron Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Biotron Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see BIT market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$551.89K
≈ $390.50K
AU$-565.80K
≈ $-400.34K
-1.025x -107.01%
2024-06-30 AU$-244.03K
≈ $-172.67K
AU$-3.57 Million
≈ $-2.52 Million
14.623x +1510.16%
2023-06-30 AU$3.17 Million
≈ $2.24 Million
AU$-3.29 Million
≈ $-2.33 Million
-1.037x +53.49%
2022-06-30 AU$1.09 Million
≈ $773.01K
AU$-2.44 Million
≈ $-1.72 Million
-2.230x -152.78%
2021-06-30 AU$3.86 Million
≈ $2.73 Million
AU$-3.41 Million
≈ $-2.41 Million
-0.882x -99.59%
2020-06-30 AU$6.97 Million
≈ $4.93 Million
AU$-3.08 Million
≈ $-2.18 Million
-0.442x -60.48%
2019-06-30 AU$5.44 Million
≈ $3.85 Million
AU$-1.50 Million
≈ $-1.06 Million
-0.275x +80.84%
2018-06-30 AU$1.28 Million
≈ $906.75K
AU$-1.84 Million
≈ $-1.30 Million
-1.437x +26.95%
2017-06-30 AU$1.44 Million
≈ $1.02 Million
AU$-2.83 Million
≈ $-2.00 Million
-1.968x -100.34%
2016-06-30 AU$3.14 Million
≈ $2.22 Million
AU$-3.08 Million
≈ $-2.18 Million
-0.982x -49.61%
2015-06-30 AU$4.14 Million
≈ $2.93 Million
AU$-2.72 Million
≈ $-1.92 Million
-0.656x +69.35%
2014-06-30 AU$1.39 Million
≈ $983.02K
AU$-2.98 Million
≈ $-2.11 Million
-2.142x -210.15%
2013-06-30 AU$4.48 Million
≈ $3.17 Million
AU$-3.09 Million
≈ $-2.19 Million
-0.691x -149.63%
2012-06-30 AU$8.27 Million
≈ $5.85 Million
AU$-2.29 Million
≈ $-1.62 Million
-0.277x +66.27%
2011-06-30 AU$2.40 Million
≈ $1.70 Million
AU$-1.97 Million
≈ $-1.39 Million
-0.820x +24.19%
2010-06-30 AU$1.72 Million
≈ $1.22 Million
AU$-1.86 Million
≈ $-1.31 Million
-1.082x +51.88%
2009-06-30 AU$841.51K
≈ $595.42K
AU$-1.89 Million
≈ $-1.34 Million
-2.249x -155.50%
2008-06-30 AU$1.84 Million
≈ $1.30 Million
AU$-1.62 Million
≈ $-1.15 Million
-0.880x +67.26%
2007-06-30 AU$1.36 Million
≈ $959.47K
AU$-3.65 Million
≈ $-2.58 Million
-2.688x -576.13%
2006-06-30 AU$4.50 Million
≈ $3.18 Million
AU$-1.79 Million
≈ $-1.26 Million
-0.398x +47.04%
2005-06-30 AU$2.28 Million
≈ $1.61 Million
AU$-1.71 Million
≈ $-1.21 Million
-0.751x +14.84%
2004-06-30 AU$2.96 Million
≈ $2.09 Million
AU$-2.61 Million
≈ $-1.84 Million
-0.882x -344.86%
2002-06-30 AU$8.49 Million
≈ $6.01 Million
AU$-1.68 Million
≈ $-1.19 Million
-0.198x -52.42%
2001-06-30 AU$10.08 Million
≈ $7.13 Million
AU$-1.31 Million
≈ $-927.34K
-0.130x --

About Biotron Ltd

AU:BIT Australia Biotechnology
Market Cap
$3.82 Million
AU$5.40 Million AUD
Market Cap Rank
#29042 Global
#1597 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.30
About

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.